Global Bioinformatics Market Size, Share, and COVID-19 Impact Analysis, By Product (Bioinformatics Platforms and Bioinformatics Services), By Application (Genomics, Cheminformatics, Metabolomics, and Proteomics), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Bioinformatics Market Insights Forecasts to 2035

• The Global Bioinformatics Market Size Was Estimated at USD 13.4 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 15.24% from 2025 to 2035
• The Worldwide Bioinformatics Market Size is Expected to Reach USD 63.8 Billion by 2035
• Asia Pacific is Expected to Grow the Fastest during the forecast period.

The Global Bioinformatics Market Size was worth around USD 13.4 Billion in 2024 and is predicted to grow to around USD 63.8 Billion by 2035 with a compound annual growth rate (CAGR) of 15.24% from 2025 and 2035. The bioinformatics market offers future opportunities in precision medicine, drug discovery, genomics, AI-driven data analysis, personalized healthcare solutions, biotechnology research, clinical diagnostics, big data integration, and growing demand for computational biology worldwide.

Market Overview

The bioinformatics market refers to the integration of biology, computer science, and information technology to analyze and interpret complex biological data, particularly in genomics, proteomics, and drug discovery. Growing demand for personalized medicine, rapid advancements in next-generation sequencing (NGS), and rising adoption of artificial intelligence (AI) for predictive analysis are major driving factors. Government initiatives such as funding for genome projects and digital healthcare transformation are boosting adoption globally. Recent developments include cloud-based bioinformatics platforms and AI-powered tools for faster drug discovery. Statistically, over 60% of pharmaceutical and biotechnology companies are increasingly investing in bioinformatics solutions, while more than 70% of genomic research projects worldwide currently rely on advanced computational tools, highlighting its expanding role in modern life sciences and healthcare.